BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 7919584)

  • 1. Pathogenesis of atherosclerosis.
    Segrest JP; Anantharamaiah GM
    Curr Opin Cardiol; 1994 Jul; 9(4):404-10. PubMed ID: 7919584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease.
    Hovingh GK; Brownlie A; Bisoendial RJ; Dube MP; Levels JH; Petersen W; Dullaart RP; Stroes ES; Zwinderman AH; de Groot E; Hayden MR; Kuivenhoven JA; Kastelein JJ
    J Am Coll Cardiol; 2004 Oct; 44(7):1429-35. PubMed ID: 15464323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol feeding impedes early atherosclerosis in low-density lipoprotein receptor knockout mice: factors in addition to high-density lipoprotein-apolipoprotein A1 are involved.
    Dai J; Miller BA; Lin RC
    Alcohol Clin Exp Res; 1997 Feb; 21(1):11-8. PubMed ID: 9046367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice.
    Inoue K; Arai Y; Kurihara H; Kita T; Sawamura T
    Circ Res; 2005 Jul; 97(2):176-84. PubMed ID: 15961718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma lipoproteins in humans: metabolism and relation to atherosclerosis].
    Seidel D
    Z Kardiol; 1984; 73 Suppl 2():23-8. PubMed ID: 6528700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic control of susceptibility to atherosclerosis (with special emphasis on the role of the macrophage).
    Clarke A; Stewart-Phillips JL; Skamene E
    Clin Invest Med; 1987 Nov; 10(6):499-512. PubMed ID: 3326693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary atherosclerosis. A multifactorial disease.
    Badimon JJ; Fuster V; Chesebro JH; Badimon L
    Circulation; 1993 Mar; 87(3 Suppl):II3-16. PubMed ID: 8443920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
    Tschudi MR; Noll G; Lüscher TP
    Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical morphology of human atherosclerotic lesions. Lessons from the PDAY Study. Pathobiological Determinants of Atherosclerosis in Youth.
    Cornhill JF; Herderick EE; Vince DG
    Wien Klin Wochenschr; 1995; 107(18):540-3. PubMed ID: 7483640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allograft vasculopathy versus atherosclerosis.
    Rahmani M; Cruz RP; Granville DJ; McManus BM
    Circ Res; 2006 Oct; 99(8):801-15. PubMed ID: 17038650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferator-activated receptor gamma-dependent pathway.
    Barlic J; Zhang Y; Foley JF; Murphy PM
    Circulation; 2006 Aug; 114(8):807-19. PubMed ID: 16908772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human urotensin II as a link between hypertension and coronary artery disease.
    Watanabe T; Kanome T; Miyazaki A; Katagiri T
    Hypertens Res; 2006 Jun; 29(6):375-87. PubMed ID: 16940699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
    Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J
    Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oxidized low-density lipoprotein on vascular contraction and relaxation: clinical and pharmacological implications in atherosclerosis.
    Cox DA; Cohen ML
    Pharmacol Rev; 1996 Mar; 48(1):3-19. PubMed ID: 8685247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of endothelial dysfunction in the pathogenesis and in clinical practice of atherosclerosis. Current evidences].
    Patti G; Melfi R; Di Sciascio G
    Recenti Prog Med; 2005 Oct; 96(10):499-507. PubMed ID: 16491775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice.
    Shiraishi Y; Watanabe T; Suguro T; Nagashima M; Kato R; Hongo S; Itabe H; Miyazaki A; Hirano T; Adachi M
    J Hypertens; 2008 Oct; 26(10):1955-65. PubMed ID: 18806619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of LDL in the origin and progression of atherosclerosis: pathobiological concepts on the origin and development of atherosclerotic lesions and the role of the endothelium].
    De Caterina R; Lenzi S
    G Ital Cardiol; 1998 Feb; 28(2):158-67. PubMed ID: 9534057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary cholate is required for antiatherogenic effects of ethanol in mouse models.
    Deeg MA
    Alcohol Clin Exp Res; 2003 Sep; 27(9):1499-506. PubMed ID: 14506412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals.
    Takahashi K; Takeya M; Sakashita N
    Med Electron Microsc; 2002 Dec; 35(4):179-203. PubMed ID: 12658354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments in atherogenesis.
    Stein O; Stein Y
    Arzneimittelforschung; 1990 Mar; 40(3A):348-50. PubMed ID: 2185761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.